Charlie from United Kingdom

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

CARA Therapeutics, Inc. (CARA) shares information

CARA Therapeutics, Inc.

24h Change

4.26 %


Live rate: Market closed

Stock data per Monday 3 Aug, 2020

0.7 (+ 4.26%)
US Market is closed

Live Stock price in graph for CARA Therapeutics, Inc. (CARA)

  • Latest Volume

    463,696 (55.07 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high


  • Today low


  • 52 week high


  • 52 week low


  • YTD Change

    + 10.73 %

Quick links

Broker recommendations for CARA Therapeutics

The CARA Therapeutics, Inc. stock is rated at 1.125 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Thursday 28 May, 2020 by a total of 8 brokers. This means that the consensus of the 8 different brokers is leaning toward to buy/moderate buy.

0 (0%)
0 (0%)
1 (12.5%)
0 (0%)
7 (87.5%)

Price target by analysts

The 8 latest analyst estimates, per Saturday 1 August, 2020, show the following high, low and average price targets.
Target Average: 33.12 USD
Target High: 40 USD
Target Low: 19 USD


Latest news about CARA Therapeutics, Inc.

Below you can find the most recent news posts about CARA Therapeutics, Inc., primarily from US and UK based news sources.

Debate on population versus land mass turn into 2022 politics

Monday, 27 July 2020, 23:00:00
The stalemate has stalled the passage of the County Allocation of Revenue (CARA) Bill 2020, which will allow counties to get funds.
— The Standard Digital

Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff, Ph.D., M.B.A.

Tuesday, 30 June 2020, 13:00:00
STAMFORD, Conn., June 30, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and…
— GlobeNewswire

Cara Therapeutics to Present at the Jefferies Virtual Healthcare Conference

Wednesday, 27 May 2020, 22:01:00
STAMFORD, Conn., May 27, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and…
— GlobeNewswire

Is Cara Therapeutics (CARA) Stock a Solid Choice Right Now?

Friday, 15 May 2020, 17:00:00
Cara Therapeutics (CARA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
— Zacks Investment Research

Earnings Preview: Cara Therapeutics (CARA) Q1 Earnings Expected to Decline

Tuesday, 28 April 2020, 18:34:08
Cara (CARA) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
— Zacks Investment Research